Laboratory measurement of bleeding risk for patients receiving Dabigatran
10.13602/j.cnki.jcls.2017.12.08
- VernacularTitle:达比加群服药患者出血风险的实验室检测
- Author:
Chan-Juan WANG
1
;
Shuo YANG
;
Jie ZHANG
;
Rui QIAO
Author Information
1. 北京大学第三医院检验科
- Keywords:
Dabigatran;
activated partial thromboplastin time;
diluted Russell viper venom time;
thromboelastogram;
bleeding event
- From:
Chinese Journal of Clinical Laboratory Science
2017;35(12):908-912
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the correlation between conventional coagulation tests and Dabigatran concentration in order to find proper test method to predict the bleeding risk of patients receiving Dabigatran.Methods The clinical data of forty-nine non-valvular atrial fibrillation (NVAF) patients who took Dabigatran in Peking University Third Hospital from 2015 to 2017 were analyzed and the bleeding rates were calculated.The plasma samples from twenty healthy volunteers were collected and mixed up into normal pooled plasma (NPP).Different doses of active Dabigatran were mixed with NPP,making Dabigatran concentrations from 0 to 1 000 ng/mL.Prothrombin time (PT),activated partial thromboplastin time (APTT),thrombin time (TT),fibrinogen (Fib) and diluted Russell viper venom time (dRVVT) were determined.Fresh whole blood samples from three normal volunteers were collected and mixed with Dabigatran in the same way to perform thromboelastogram (TEG).Results The total bleeding rate of NVAF patients receiving Dabigatran was 28.6％,among which gastrointestinal bleeding accounts for the most.APTT,dRVVT,R time (R) and clot index (CI) showed a good linear correlation with Dabigatran concentration.The sensitivity of dRVVT was the best,followed by APTT.R and CI showed low sensitivity compared with APTT and dRVVT.Conclusion APTT and dRVVT should be good parameters for monitoring the bleeding risk of Dabigatran and helpful for physicians to choose proper point-in-time for withdrawal of Dabigatran and reduce bleeding events.
